Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
14
PRPH Quote, Financials, Valuation and Earnings
Last price:
$0.14
Seasonality move
:
18.71%
Day range:
$0.13 - $0.14
52-week range:
$0.12 - $0.93
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.93x
P/B ratio:
0.91x
Volume:
3.9M
Avg. volume:
2.6M
1-year change:
-82.56%
Market cap:
$6.2M
Revenue:
$6.8M
EPS (TTM):
-$0.75
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, ProPhase Labs, Inc. has 10099.56% upside to fair value with a price target of $13.80 per share.
PRPH vs. S&P 500
-
Over the past 5 trading days, ProPhase Labs, Inc. has underperformed the S&P 500 by -24.76% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
ProPhase Labs, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
ProPhase Labs, Inc. revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter ProPhase Labs, Inc. reported revenues of $883K.
Earnings Growth
-
ProPhase Labs, Inc. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter ProPhase Labs, Inc. reported earnings per share of -$0.16.
Enterprise value:
13.5M
EV / Invested capital:
0.93x
Price / LTM sales:
0.93x
EV / EBIT:
--
EV / Revenue:
2.72x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-1.21x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$796.5K
Return On Assets:
-30.47%
Net Income Margin (TTM):
-421.02%
Return On Equity:
-90.24%
Return On Invested Capital:
-51.85%
Operating Margin:
-539.52%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $62.7M | $8.8M | $5M | $1.4M | $883K | |
| Gross Profit | $30.6M | -$3.9M | -$796.5K | -$604.5K | -$650.5K | |
| Operating Income | -$15.4M | -$32.7M | -$17.4M | -$6.5M | -$4.8M | |
| EBITDA | -$9.6M | -$25.8M | -$11.7M | -$4.8M | -$3.7M | |
| Diluted EPS | -$0.62 | -$1.52 | -$0.75 | -$0.35 | -$0.16 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $43.9M | $70.3M | $49.8M | $42.2M | $7.8M | |
| Total Assets | $72.6M | $97.9M | $91.7M | $91.8M | $65.7M | |
| Current Liabilities | $9.9M | $16.7M | $16.4M | $28.7M | $55.3M | |
| Total Liabilities | $24.4M | $30M | $35.3M | $53.7M | $58.8M | |
| Total Equity | $48.3M | $67.9M | $56.4M | $38.1M | $6.9M | |
| Total Debt | $15M | $12.3M | $17.9M | $26M | $3.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$10.3M | -$14.2M | -$11.2M | -$4M | -$3.5M | |
| Cash From Investing | -$5.1M | $1.2M | $823K | -$97K | -- | |
| Cash From Financing | -$6.7M | $13.4M | $8.8M | $2.9M | $3.7M | |
| Free Cash Flow | -$13.8M | -$16.4M | -$11.2M | -$4M | -$3.5M | |
PRPH
Sector
Market Cap
$6.2M
$28.4M
Price % of 52-Week High
14.47%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-2.25%
-1.32%
1-Year Price Total Return
-82.56%
-22.19%
Beta (5-Year)
-0.657
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.18
200-day SMA
Sell
Level
$0.37
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$0.23
Relative Strength Index (RSI14)
Sell
Level
26.11
ADX Line
Neutral
Level
0
Williams %R
Buy
Level
-92.7887
50-day SMA
Sell
Level
$0.37
MACD (12, 26)
Sell
Level
-0.06
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.9888)
Sell
CA Score
(Annual)
Level (-3.2931)
Buy
Beneish M-Score
(Annual)
Level (-14.6821)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (6.5472)
Sell
Piotroski F Score
(Annual)
Level (2)
Sell
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Garden City, NY.
Stock Forecast FAQ
In the current month, PRPH has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PRPH average analyst price target in the past 3 months is $13.80.
-
Where Will ProPhase Labs, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that ProPhase Labs, Inc. share price will rise to $13.80 per share over the next 12 months.
-
What Do Analysts Say About ProPhase Labs, Inc.?
Analysts are divided on their view about ProPhase Labs, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that ProPhase Labs, Inc. is a Sell and believe this share price will drop from its current level to $13.80.
-
What Is ProPhase Labs, Inc.'s Price Target?
The price target for ProPhase Labs, Inc. over the next 1-year time period is forecast to be $13.80 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PRPH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for ProPhase Labs, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of PRPH?
You can purchase shares of ProPhase Labs, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase ProPhase Labs, Inc. shares.
-
What Is The ProPhase Labs, Inc. Share Price Today?
ProPhase Labs, Inc. was last trading at $0.14 per share. This represents the most recent stock quote for ProPhase Labs, Inc.. Yesterday, ProPhase Labs, Inc. closed at $0.14 per share.
-
How To Buy ProPhase Labs, Inc. Stock Online?
In order to purchase ProPhase Labs, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get PRPH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PRPH
Sector
P/E ratio
--
23.66x
PEG ratio
0.00x
-0.01x
P/B ratio
0.91x
1.84x
Price / LTM sales
0.93x
1.60x
Growth Metrics
PRPH
Sector
Revenue growth
-41.29%
4.85%
Earnings growth
49.48%
11.15%
Revenue (5-year growth)
-7.27%
6.45%
Earnings forecast
-$0.15
-$0.20
Profitability
PRPH
Sector
Profitability FY 2024
-$150K
$3.6M
Return on invested capital
-51.85%
-30.98%
Return on assets
-30.47%
-27.62%
Return on equity
-90.24%
-36.69%
Earnings Date
Last Earnings Date
Nov
19
Next Earnings Date
Mar
30
Estimated Next Earnings Date
Feb
18
Balance Sheet
PRPH
Sector
Total cash
$405K
$27.2M
Short term investments
--
$25.7M
Total assets
$63.2M
$79.9M
Long term debt
$3.5M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
